Imagenetix Inc
Imagenetix, Inc. engages in the research, development, and commercialization of compositions to reduce body fat and enhance overall body composition. It offers an inference engine for CT, MRI, and X ray studies, a clinician review workstation that surfaces model outputs within the diagnostic viewer, and an enterprise analytics hub for quality and utilization reporting. The company was founded in … Read more
Imagenetix Inc (IAGX) - Net Assets
Latest net assets as of June 2015: $6.29 Million USD
Based on the latest financial reports, Imagenetix Inc (IAGX) has net assets worth $6.29 Million USD as of June 2015.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.94 Million) and total liabilities ($2.65 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.29 Million |
| % of Total Assets | 70.39% |
| Annual Growth Rate | 91.1% |
| 5-Year Change | 80.66% |
| 10-Year Change | 51.78% |
| Growth Volatility | 95560.73 |
Imagenetix Inc - Net Assets Trend (2000–2015)
This chart illustrates how Imagenetix Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Imagenetix Inc (2000–2015)
The table below shows the annual net assets of Imagenetix Inc from 2000 to 2015.
| Year | Net Assets | Change |
|---|---|---|
| 2015-03-31 | $6.33 Million | +0.13% |
| 2014-03-31 | $6.32 Million | +225.17% |
| 2013-03-31 | $-5.05 Million | -342.80% |
| 2011-03-31 | $2.08 Million | -40.63% |
| 2010-03-31 | $3.51 Million | -13.52% |
| 2009-03-31 | $4.05 Million | +17.39% |
| 2008-03-31 | $3.45 Million | -24.50% |
| 2007-03-31 | $4.57 Million | -7.72% |
| 2006-03-31 | $4.96 Million | +18.76% |
| 2005-03-31 | $4.17 Million | +162.46% |
| 2004-03-31 | $1.59 Million | +66.02% |
| 2003-03-31 | $957.51K | -27.54% |
| 2002-03-31 | $1.32 Million | -3.81% |
| 2001-03-31 | $1.37 Million | +358601.57% |
| 2000-03-31 | $383.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Imagenetix Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9000700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2015)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $28.37K | 0.45% |
| Other Components | $6.33 Million | 99.89% |
| Total Equity | $6.33 Million | 100.00% |
Imagenetix Inc Competitors by Market Cap
The table below lists competitors of Imagenetix Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Creative Vistas Inc
PINK:CVAS
|
$1.92 |
|
4Cable Tv Internatio
PINK:CATV
|
$1.92 |
|
Starwin Media Holdings Inc
OTCGREY:SWMD
|
$1.92 |
|
Manthey Redmond Corp
PINK:MHYR
|
$1.92 |
|
Ceres Ventures Inc
PINK:CEVE
|
$1.92 |
|
Cygnus eTransaction Group Inc
PINK:CYGT
|
$1.92 |
|
Profitable Develop
PINK:PRDL
|
$1.91 |
|
Qed Connect Inc
PINK:QEDN
|
$1.91 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imagenetix Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2014 to 2015, total equity changed from 6,324,349 to 6,332,637, a change of 8,288 (0.1%).
- Net loss of 21,712 reduced equity.
Equity Change Factors (2014 to 2015)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-21.71K | -0.34% |
| Other Changes | $30.00K | +0.47% |
| Total Change | $- | 0.13% |
Book Value vs Market Value Analysis
This analysis compares Imagenetix Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.18x to 0.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-03-31 | $0.00 | $0.00 | x |
| 2001-03-31 | $0.17 | $0.00 | x |
| 2002-03-31 | $0.15 | $0.00 | x |
| 2003-03-31 | $0.11 | $0.00 | x |
| 2004-03-31 | $0.15 | $0.00 | x |
| 2005-03-31 | $0.43 | $0.00 | x |
| 2006-03-31 | $0.47 | $0.00 | x |
| 2007-03-31 | $0.43 | $0.00 | x |
| 2008-03-31 | $0.32 | $0.00 | x |
| 2009-03-31 | $0.37 | $0.00 | x |
| 2010-03-31 | $0.32 | $0.00 | x |
| 2011-03-31 | $0.18 | $0.00 | x |
| 2015-03-31 | $0.22 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imagenetix Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.63%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 1.40x
- Recent ROE (-0.34%) is above the historical average (-207.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -2424.80% | -928700.00% | 0.00x | 13.65x | $-9.33K |
| 2001 | -26.22% | -7.76% | 2.49x | 1.36x | $-497.62K |
| 2002 | -19.38% | -5.76% | 2.09x | 1.61x | $-388.18K |
| 2003 | -80.99% | -22.75% | 1.97x | 1.81x | $-871.24K |
| 2004 | 29.25% | 10.18% | 1.90x | 1.51x | $306.07K |
| 2005 | 18.07% | 9.95% | 1.31x | 1.38x | $336.71K |
| 2006 | -11.98% | -7.76% | 1.30x | 1.19x | $-1.09 Million |
| 2007 | -14.60% | -11.93% | 1.06x | 1.15x | $-1.12 Million |
| 2008 | -51.46% | -31.90% | 1.27x | 1.27x | $-2.12 Million |
| 2009 | 10.61% | 5.76% | 1.63x | 1.13x | $24.64K |
| 2010 | -19.89% | -10.57% | 1.40x | 1.34x | $-1.05 Million |
| 2011 | -104.16% | -30.41% | 1.20x | 2.84x | $-2.38 Million |
| 2015 | -0.34% | -2.63% | 0.09x | 1.40x | $-654.98K |
Industry Comparison
This section compares Imagenetix Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imagenetix Inc (IAGX) | $6.29 Million | -2424.80% | 0.42x | $1.92 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |